**Part 4**

**Breast Cancer Gene Regulation** 

288 Breast Cancer – Focusing Tumor Microenvironment, Stem Cells and Metastasis

[95] Ji, Q. et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.

[96] Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis

[97] Godlewski, J. et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by

[98] Venkataraman, S. et al. MicroRNA 128a increases intracellular ROS level by targeting

[99] Kent, O. A. et al. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol Ther 8, 2013-24 (2009). [100] Iliopoulos, D. et al. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated

[101] Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65, 9628-32 (2005). [102] He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-

[103] Wong, P. et al. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell

[104] Connolly, E. et al. Elevated expression of the miR-17-92 polycistron and miR-21 in

[105] Uziel, T. et al. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in

[106] Monzo, M. et al. Overlapping expression of microRNAs in human embryonic colon

[107] Ji, J. et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50, 472-80 (2009). [108] Wang, Y. et al. Transforming growth factor-beta regulates the sphere-initiating stem celllike feature in breast cancer through miRNA-181 and ATM. Oncogene 30, 1470-80. [109] Thiery, J. P. Epithelial-mesenchymal transitions in development and pathologies. Curr

[110] Gregory, P. A. et al. An autocrine TGF-{beta}/ZEB/miR-200 signaling network

[111] Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing

[112] Kong, D. et al. Epithelial to mesenchymal transition is mechanistically linked with

stemness-inhibiting microRNAs. Nat Cell Biol 11, 1487-95 (2009).

stem cell signatures in prostate cancer cells. PLoS One 5, e12445.

regulates establishment and maintenance of epithelial-mesenchymal transition. Mol

potential by modulating p21 expression. Cancer Res 70, 3833-42.

medulloblastoma. Proc Natl Acad Sci U S A 106, 2812-7 (2009).

phenotype. Am J Pathol 173, 856-64 (2008).

Opin Cell Biol 15, 740-6 (2003).

and colorectal cancer. Cell Res 18, 823-33 (2008).

microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68, 9125-

Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.

repression required for the formation and maintenance of cancer stem cells. Mol

hepadnavirus-associated hepatocellular carcinoma contributes to the malignant

PLoS One 4, e6816 (2009).

30 (2008).

PLoS One 5, e10748.

Cell 39, 761-72.

33 (2005).

Biol Cell.

by directly repressing CD44. Nat Med 17, 211-5.

**14** 

Majed Saleh Alokail

*King Saud University* 

*Saudi Arabia* 

**Epigenetics and Breast Cancer** 

The term epigenetic was introduced by Conard Waddington in 1942 as a concept of environmental influence in inducing phenotype modification. His work on developmental plasticity states that the environmental influences during development could induce alternative phenotypes from one genotype, one of the clearest examples is polyphenisms in insects. He showed that exposing the pupae of wild type Drosophila melanogaster to heat shock treatment, results in altered wing vein patterns (Waddington, 1952;Waddington, 1959a). Breeding individuals who have been exposed to these environmentally induced changes led to a stable population exhibiting the phenotype without the environmental stimulus. As a result of Waddington's observations of the dynamic interaction between genes and variation in the environment during the plastic phase of development, he described phenotype induction as genetic canalization. Canalization describes the robustness of phenotypes in response to perturbation (Waddington, 1959b;Waddington,

The epigenome controls the genome in both normal and abnormal cellular processes and events (Szyf et al., 2008;Vaissiere et al., 2008). Epigenetic system includes DNA methylation and histone modification and non-coding RNAs, which work cooperatively to control gene expression. As a result, epigenetic mechanisms are essential for normal development and maintenance of tissue-specific gene expression patterns in mammals. Disruption of epigenetic processes can lead to altered gene function and malignant cellular transformation. Global changes in the epigenetic landscape are a hallmark of cancer (Hanahan & Weinberg, 2000). Methylation of cytosine bases in DNA provides a layer of epigenetic control in many eukaryotes that has important implications for normal biology and disease. DNA methylation is a crucial epigenetic modification of the genome that is involved in regulating many cellular processes. These include embryonic development, transcription, chromatin structure, X-chromosome inactivation, genomic imprinting, and

Additionally, in 1975, DNA methylation was related to the process of X chromosome inactivation in females (Riggs, 1975). Since then, it has been used as a marker for gene silencing and extensively studied as an important mechanism of epigenetic control (Jaenisch & Bird, 2003). For instance, methylation of CpG islands within the imprinted gene promoters ensures transcriptional silencing of the associated parental allele (Nafee et al., 2008). Consistent with these important roles, a growing number of human diseases

**1. Introduction** 

1961;Waddington & Robertson, 1966).

chromosome stability.

*Department of Biochemistry, College of Science* 
